olmesartan medoxomil-hydrochlorothiazide
Generic: olmesartan medoxomil-hydrochlorothiazide
Labeler: novadoz pharmaceuticals llcDrug Facts
Product Profile
Brand Name
olmesartan medoxomil-hydrochlorothiazide
Generic Name
olmesartan medoxomil-hydrochlorothiazide
Labeler
novadoz pharmaceuticals llc
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
hydrochlorothiazide 12.5 mg/1, olmesartan medoxomil 40 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72205-148
Product ID
72205-148_c8197eea-e990-4c0e-bc2d-f080bac8de17
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA217398
Listing Expiration
2026-12-31
Marketing Start
2025-09-26
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72205148
Hyphenated Format
72205-148
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
olmesartan medoxomil-hydrochlorothiazide (source: ndc)
Generic Name
olmesartan medoxomil-hydrochlorothiazide (source: ndc)
Application Number
ANDA217398 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 12.5 mg/1
- 40 mg/1
Packaging
- 30 TABLET, FILM COATED in 1 BOTTLE (72205-148-30)
- 90 TABLET, FILM COATED in 1 BOTTLE (72205-148-90)
- 1000 TABLET, FILM COATED in 1 BOTTLE (72205-148-99)
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c8197eea-e990-4c0e-bc2d-f080bac8de17", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0372205148307", "0372205147300", "0372205147904", "0372205148994", "0372205149304", "0372205148901", "0372205147997", "0372205149991", "0372205149908"], "unii": ["0J48LPH2TH", "6M97XTV3HD"], "rxcui": ["403853", "403854", "403855"], "spl_set_id": ["c8197eea-e990-4c0e-bc2d-f080bac8de17"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (72205-148-30)", "package_ndc": "72205-148-30", "marketing_start_date": "20250930"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (72205-148-90)", "package_ndc": "72205-148-90", "marketing_start_date": "20250930"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (72205-148-99)", "package_ndc": "72205-148-99", "marketing_start_date": "20250930"}], "brand_name": "olmesartan medoxomil-hydrochlorothiazide", "product_id": "72205-148_c8197eea-e990-4c0e-bc2d-f080bac8de17", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "72205-148", "generic_name": "olmesartan medoxomil-hydrochlorothiazide", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "olmesartan medoxomil-hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "40 mg/1"}], "application_number": "ANDA217398", "marketing_category": "ANDA", "marketing_start_date": "20250926", "listing_expiration_date": "20261231"}